Search Result "D-JNKI and I-JIP"
Targeting the JNK Signaling Pathway for Stroke and Parkinsons Diseases Therapy
Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 4 Issue: 1 Year: 2005 Page: 63-67
Author(s): Chia-Yi Kuan, Robert E. Burke
JNK Signalling: A Possible Target to Prevent Neurodegeneration
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 1 Year: 2007 Page: 1875-1886
Author(s): Tiziana Borsello, Gianluigi Forloni
The MAPK / JNK Signalling Pathway Offers Potential Therapeutic Targets for the Prevention of Acquired Deafness
Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 3 Issue: 4 Year: 2004 Page: 325-332
Author(s): A. Zine, T. R. Van De Water
Targeting Stress Activated Protein Kinases, JNK and p38, as New Therapeutic Approach for Neurodegenerative Diseases
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 6 Issue: 2 Year: 2006 Page: 109-117
Author(s): Caterina Bendotti, Massimo Tortarolo, Tiziana Borsello
From Cochlear Cell Death Pathways To New Pharmacological Therapies
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 8 Issue: 1 Year: 2008 Page: 1006-1019
Author(s): Jing Wang, Jean-Luc Puel
Cell-Permeable Peptide Inhibitor of c-Jun NH2-Terminal Kinase for the Treatment of Diabetes
Journal: Current Bioactive Compounds
Volume: 6 Issue: 1 Year: 2010 Page: 23-30
Author(s): Hirofumi Noguchi
Blocking Apoptotic Intracellular Signaling Cascades with Cell-Permeable Peptides
Journal: Current Signal Transduction Therapy
Volume: 2 Issue: 2 Year: 2007 Page: 175-179
Author(s): Azel Zine, Alain Uziel, Jacques Beckmann, Christophe Bonny
Peptides as Signaling Inhibitors for Mammalian MAP Kinase Cascades
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 2471-2480
Author(s): Matthias Gaestel, Michael Kracht
Recent Advances in c-Jun N-Terminal Kinase (JNK) Inhibitors
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 3 Year: 2021 Page: 607-627
Author(s): Gang Li,Wenqing Qi,Xiaoxun Li,Jinwu Zhao,Meihua Luo,Jianjun Chen
The Injured Cochlea as a Target for Inflammatory Processes, Initiation of Cell Death Pathways and Application of Related Otoprotective Strategies
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 5 Issue: 2 Year: 2010 Page: 147-163
Author(s): Ralph N. Abi-Hachem, Azel Zine, Thomas R. Van De Water